BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 37478493)

  • 1. Cost-Effectiveness of Four Tobacco Control Interventions in Mongolia.
    Tuvdendorj A; Feenstra T; Buskens E
    Nicotine Tob Res; 2023 Sep; 25(11):1719-1726. PubMed ID: 37478493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of Evidence.
    Ekpu VU; Brown AK
    Tob Use Insights; 2015; 8():1-35. PubMed ID: 26242225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reducing the Burden of Disease Through Tobacco Taxes in Mongolia: A Health Impact Analysis Using a Dynamic Public Health Model.
    Tuvdendorj A; Konings SRA; Purevdorj B; Buskens E; Feenstra TL
    Nicotine Tob Res; 2022 Feb; 24(2):233-240. PubMed ID: 34498055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of 13-valent pneumococcal conjugate vaccination in Mongolia.
    Sundaram N; Chen C; Yoong J; Luvsan ME; Fox K; Sarankhuu A; La Vincente S; Jit M
    Vaccine; 2017 Feb; 35(7):1055-1063. PubMed ID: 28109706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moving towards malaria elimination in southern Mozambique: Cost and cost-effectiveness of mass drug administration combined with intensified malaria control.
    Cirera L; Galatas B; Alonso S; Paaijmans K; Mamuquele M; Martí-Soler H; Guinovart C; Munguambe H; Luis F; Nhantumbo H; Montañà J; Bassat Q; Candrinho B; Rabinovich R; Macete E; Aide P; Alonso P; Saúte F; Sicuri E
    PLoS One; 2020; 15(7):e0235631. PubMed ID: 32628741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-Effectiveness of Population-Based Tobacco Control Interventions on the Health Burden of Cardiovascular Diseases in Vietnam.
    Nguyen DT; Luong KN; Phan HT; Tran AT; Dao ST; Poudel AN; Hoang TM; Do VV; Le DM; Pham GH; Nguyen LT; Duong AT; Hoang MV
    Asia Pac J Public Health; 2021 Nov; 33(8):854-860. PubMed ID: 33764194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Costs, health effects and cost-effectiveness of alcohol and tobacco control strategies in Estonia.
    Lai T; Habicht J; Reinap M; Chisholm D; Baltussen R
    Health Policy; 2007 Nov; 84(1):75-88. PubMed ID: 17403551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smoking-attributable burden of lung cancer in Mongolia a data synthesis study on differences between men and women.
    Tuvdendorj A; Feenstra T; Tseveen B; Buskens E
    PLoS One; 2020; 15(2):e0229090. PubMed ID: 32059049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of the burden of cardiovascular disease attributable to modifiable risk factors and cost-effectiveness analysis of preventative interventions to reduce this burden in Argentina.
    Rubinstein A; Colantonio L; Bardach A; Caporale J; Martí SG; Kopitowski K; Alcaraz A; Gibbons L; Augustovski F; Pichón-Rivière A
    BMC Public Health; 2010 Oct; 10():627. PubMed ID: 20961456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost effectiveness of strategies to combat cardiovascular disease, diabetes, and tobacco use in sub-Saharan Africa and South East Asia: mathematical modelling study.
    Ortegón M; Lim S; Chisholm D; Mendis S
    BMJ; 2012 Mar; 344():e607. PubMed ID: 22389337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reducing non-communicable diseases among Palestinian populations in Gaza: A participatory comparative and cost-effectiveness modeling assessment.
    Basu S; Yudkin JS; Jawad M; Ghattas H; Hamad BA; Jamaluddine Z; Safadi G; Ragi ME; Ahmad RES; Vamos EP; Millett C
    PLOS Glob Public Health; 2024; 4(5):e0003168. PubMed ID: 38696423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of tobacco control policies in Vietnam: the case of personal smoking cessation support.
    Higashi H; Barendregt JJ
    Addiction; 2012 Mar; 107(3):658-70. PubMed ID: 21883602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic Evaluation of Five Tobacco Control Policies Across Seven European Countries.
    Leão T; Perelman J; Clancy L; Mlinarić M; Kinnunen JM; Nuyts PAW; Mélard N; Rimpelä A; Lorant V; Kunst AE
    Nicotine Tob Res; 2020 Jun; 22(7):1202-1209. PubMed ID: 31350556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of violence against women and girls: A cost-effectiveness study across 6 low- and middle-income countries.
    Ferrari G; Torres-Rueda S; Chirwa E; Gibbs A; Orangi S; Barasa E; Tawiah T; Dwommoh Prah RK; Hitimana R; Daviaud E; Kapapa E; Dunkle K; Heise L; Stern E; Chatterji S; Omondi B; Ogum Alangea D; Karmaliani R; Maqbool Ahmed Khuwaja H; Jewkes R; Watts C; Vassall A
    PLoS Med; 2022 Mar; 19(3):e1003827. PubMed ID: 35324910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scaling up integrated prevention campaigns for global health: costs and cost-effectiveness in 70 countries.
    Marseille E; Jiwani A; Raut A; Verguet S; Walson J; Kahn JG
    BMJ Open; 2014 Jun; 4(6):e003987. PubMed ID: 24969782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The health and economic burden of smoking in 12 Latin American countries and the potential effect of increasing tobacco taxes: an economic modelling study.
    Pichon-Riviere A; Alcaraz A; Palacios A; Rodríguez B; Reynales-Shigematsu LM; Pinto M; Castillo-Riquelme M; Peña Torres E; Osorio DI; Huayanay L; Loza Munarriz C; de Miera-Juárez BS; Gallegos-Rivero V; De La Puente C; Del Pilar Navia-Bueno M; Caporale J; Roberti J; Virgilio SA; Augustovski F; Bardach A
    Lancet Glob Health; 2020 Oct; 8(10):e1282-e1294. PubMed ID: 32971051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The population cost-effectiveness of delivering universal and indicated school-based interventions to prevent the onset of major depression among youth in Australia.
    Lee YY; Barendregt JJ; Stockings EA; Ferrari AJ; Whiteford HA; Patton GA; Mihalopoulos C
    Epidemiol Psychiatr Sci; 2017 Oct; 26(5):545-564. PubMed ID: 27509769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human health benefits from livestock vaccination for brucellosis: case study.
    Roth F; Zinsstag J; Orkhon D; Chimed-Ochir G; Hutton G; Cosivi O; Carrin G; Otte J
    Bull World Health Organ; 2003; 81(12):867-76. PubMed ID: 14997239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Costs and benefits of smoking cessation aids: making a case for public reimbursement of nicotine replacement therapy in Australia.
    Bertram MY; Lim SS; Wallace AL; Vos T
    Tob Control; 2007 Aug; 16(4):255-60. PubMed ID: 17652241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mass media interventions for smoking cessation in adults.
    Bala MM; Strzeszynski L; Topor-Madry R
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD004704. PubMed ID: 29159862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.